_id
690f3759ccc777a4e85d17db
Ticker
BNXTF
Name
BioNxt Solutions Inc.
Exchange
OTCQB
Address
1928 Linden Road, Vancouver, BC, Canada, V6M 1E7
Country
USA
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
USD
Website
https://www.bionxt.com
Description
BioNxt Solutions Inc. engages in research, development, manufacture, and sale of next generation drug formulations and delivery systems in Austria, Germany, and Switzerland. The company provides BNT23001for the treatment of multiple sclerosis; BNT23002 for the treatment of myasthenia gravis; BNT24002, a sublingual thin film for the treatment of lupus nephritis; BNT24003 for the treatment of rheumatoid arthritis; BNT24004 for longevity and anti-aging; and BNT24004 for the treatment of semaglutide. It also offers diagnostic screening tests; new active pharmaceutical production and evaluation, including precision transdermal and oral dissolvable drug formulations; infectious disease and oral health screening tests; and standardization and clinical evaluation of emerging active pharmaceutical ingredients for neurological applications. The company was formerly known as XPhyto Therapeutics Corp. and changed its name to BioNxt Solutions Inc. in November 2022. BioNxt Solutions Inc. was incorporated in 2017 and is headquartered in Vancouver, Canada.
Last Close
0.3451
Volume
2100
Current Price
0.3642
Change
-0.0117
Last Updated
2026-01-20T16:50:31.649Z
Image
-
Ipo Date
-
Market Cap
44609224
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
11256
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
1305531
Operating Income
-1294275
Interest Expense
380640
Pretax Income
-1603758
Net Income
-1603758
Eps
-0.013235028447515016
Dividends Per Share
-
Shares Outstanding
122485519
Income Tax Expense
-
EBITDA
-
Operating Margin
-11498.534115138593
Total Other Income Expense Net
71157
Cash
468758
Short Term Investments
-
Receivables
131797
Inventories
-
Total Current Assets
877760
Property Plant Equipment
298242
Total Assets
1226004
Payables
479850
Short Term Debt
-
Long Term Debt
5603616
Total Liabilities
9536449
Equity
-8310445
Bs_currency_symbol
CAD
Depreciation
5547
Change In Working Capital
-809419
Cash From Operations
-2026460
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
2491872
Net Change In Cash
464521
Cf_currency_symbol
CAD
PE
-
PB
-5.310429144022974
ROE
19.29810016190469
ROA
-130.81180811808116
FCF
-2026460
Fcf Percent
-180.03375977256573
Piotroski FScore
0
Health Score
29
Deep Value Investing Score
1
Defensive Investing Score
6.5
Dividend Investing Score
1.5
Economic Moat Investing Score
5.3
Garp Investing Score
1.5
Growth Investing Score
1
Momentum Investing Score
3.5
Net Net Investing Score
0.5
Quality Investing Score
2
Value Investing Score
3.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
11256
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
1305531
Quarters > 0 > income Statement > operating Income
-1294275
Quarters > 0 > income Statement > interest Expense
380640
Quarters > 0 > income Statement > pretax Income
-1603758
Quarters > 0 > income Statement > net Income
-1603758
Quarters > 0 > income Statement > eps
-0.013235028447515016
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
121175259
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-11498.534115138593
Quarters > 0 > income Statement > total Other Income Expense Net
71157
Quarters > 0 > income Statement > currency_symbol
CAD
Quarters > 0 > balance Sheet > cash
468758
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
131797
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
877760
Quarters > 0 > balance Sheet > property Plant Equipment
298242
Quarters > 0 > balance Sheet > total Assets
1226004
Quarters > 0 > balance Sheet > payables
479850
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
5603616
Quarters > 0 > balance Sheet > total Liabilities
9536449
Quarters > 0 > balance Sheet > equity
-8310445
Quarters > 0 > balance Sheet > currency_symbol
CAD
Quarters > 0 > cash Flow > net Income
-1603758
Quarters > 0 > cash Flow > depreciation
5547
Quarters > 0 > cash Flow > change In Working Capital
-809419
Quarters > 0 > cash Flow > cash From Operations
-2026460
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
2491872
Quarters > 0 > cash Flow > net Change In Cash
464521
Quarters > 0 > cash Flow > currency_symbol
CAD
Quarters > 0 > ratios > PE
-0.013235028447515016
Quarters > 0 > ratios > PB
-5.310429144022974
Quarters > 0 > ratios > ROE
19.29810016190469
Quarters > 0 > ratios > ROA
-130.81180811808116
Quarters > 0 > ratios > FCF
-2026460
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-180.03375977256573
Quarters > 0 > health Score
29
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
1130556
Quarters > 1 > income Statement > operating Income
-1130556
Quarters > 1 > income Statement > interest Expense
383789
Quarters > 1 > income Statement > pretax Income
-1300300
Quarters > 1 > income Statement > net Income
-1300300
Quarters > 1 > income Statement > eps
-0.011117024193459168
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
116964754
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
214045
Quarters > 1 > income Statement > currency_symbol
CAD
Quarters > 1 > balance Sheet > cash
4237
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
75477
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
278176
Quarters > 1 > balance Sheet > property Plant Equipment
335435
Quarters > 1 > balance Sheet > total Assets
613613
Quarters > 1 > balance Sheet > payables
981601
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
4437851
Quarters > 1 > balance Sheet > total Liabilities
9023870
Quarters > 1 > balance Sheet > equity
-8410257
Quarters > 1 > balance Sheet > currency_symbol
CAD
Quarters > 1 > cash Flow > net Income
-1300300
Quarters > 1 > cash Flow > depreciation
6817
Quarters > 1 > cash Flow > change In Working Capital
141189
Quarters > 1 > cash Flow > cash From Operations
-758118
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
431500
Quarters > 1 > cash Flow > net Change In Cash
-324901
Quarters > 1 > cash Flow > currency_symbol
CAD
Quarters > 1 > ratios > PE
-0.011117024193459168
Quarters > 1 > ratios > PB
-5.065072732830876
Quarters > 1 > ratios > ROE
15.460883062194174
Quarters > 1 > ratios > ROA
-211.9088089724305
Quarters > 1 > ratios > FCF
-758118
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
35
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
1845156
Quarters > 2 > income Statement > operating Income
-1845156
Quarters > 2 > income Statement > interest Expense
253840
Quarters > 2 > income Statement > pretax Income
-1974509
Quarters > 2 > income Statement > net Income
-1974509
Quarters > 2 > income Statement > eps
-0.01704635328236504
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
115831754
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
124487
Quarters > 2 > income Statement > currency_symbol
CAD
Quarters > 2 > balance Sheet > cash
329138
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
154632
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
677776
Quarters > 2 > balance Sheet > property Plant Equipment
338562
Quarters > 2 > balance Sheet > total Assets
1016340
Quarters > 2 > balance Sheet > payables
874964
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
4155912
Quarters > 2 > balance Sheet > total Liabilities
8576991
Quarters > 2 > balance Sheet > equity
-7560651
Quarters > 2 > balance Sheet > currency_symbol
CAD
Quarters > 2 > cash Flow > net Income
-1974509
Quarters > 2 > cash Flow > depreciation
-5951
Quarters > 2 > cash Flow > change In Working Capital
-419602
Quarters > 2 > cash Flow > cash From Operations
-1315535
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
1528212
Quarters > 2 > cash Flow > net Change In Cash
296786
Quarters > 2 > cash Flow > currency_symbol
CAD
Quarters > 2 > ratios > PE
-0.01704635328236504
Quarters > 2 > ratios > PB
-5.579668312530231
Quarters > 2 > ratios > ROE
26.1155950724349
Quarters > 2 > ratios > ROA
-194.27642324418994
Quarters > 2 > ratios > FCF
-1315535
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
39
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
4566
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
1089884
Quarters > 3 > income Statement > operating Income
-1085318
Quarters > 3 > income Statement > interest Expense
265436
Quarters > 3 > income Statement > pretax Income
-1387198
Quarters > 3 > income Statement > net Income
-1297408
Quarters > 3 > income Statement > eps
-0.011440775283668676
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
113402105
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-23769.557599649586
Quarters > 3 > income Statement > total Other Income Expense Net
-36444
Quarters > 3 > income Statement > currency_symbol
CAD
Quarters > 3 > balance Sheet > cash
32352
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
60599
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
163692
Quarters > 3 > balance Sheet > property Plant Equipment
405661
Quarters > 3 > balance Sheet > total Assets
569355
Quarters > 3 > balance Sheet > payables
1112788
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
1553056
Quarters > 3 > balance Sheet > total Liabilities
8430815
Quarters > 3 > balance Sheet > equity
-7861460
Quarters > 3 > balance Sheet > currency_symbol
CAD
Quarters > 3 > cash Flow > net Income
-1297408
Quarters > 3 > cash Flow > depreciation
22784
Quarters > 3 > cash Flow > change In Working Capital
-196269
Quarters > 3 > cash Flow > cash From Operations
-1084602
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
1036552
Quarters > 3 > cash Flow > net Change In Cash
-47705
Quarters > 3 > cash Flow > currency_symbol
CAD
Quarters > 3 > ratios > PE
-0.011440775283668676
Quarters > 3 > ratios > PB
-5.2536102251999
Quarters > 3 > ratios > ROE
16.503397587725434
Quarters > 3 > ratios > ROA
-227.87329522002972
Quarters > 3 > ratios > FCF
-1084602
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-237.53876478318003
Quarters > 3 > health Score
28
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
26985
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
4594375
Annuals > 0 > income Statement > operating Income
-4567390
Annuals > 0 > income Statement > interest Expense
985148
Annuals > 0 > income Statement > pretax Income
-5401295
Annuals > 0 > income Statement > net Income
-5311505
Annuals > 0 > income Statement > eps
-0.04683779899852829
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
113402105
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-16925.662405039835
Annuals > 0 > income Statement > total Other Income Expense Net
150942
Annuals > 0 > income Statement > currency_symbol
CAD
Annuals > 0 > balance Sheet > cash
32352
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
60599
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
163692
Annuals > 0 > balance Sheet > property Plant Equipment
405661
Annuals > 0 > balance Sheet > total Assets
569355
Annuals > 0 > balance Sheet > payables
1112788
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
1553056
Annuals > 0 > balance Sheet > total Liabilities
8430815
Annuals > 0 > balance Sheet > equity
-7861460
Annuals > 0 > balance Sheet > currency_symbol
CAD
Annuals > 0 > cash Flow > net Income
-5311505
Annuals > 0 > cash Flow > depreciation
91759
Annuals > 0 > cash Flow > change In Working Capital
788268
Annuals > 0 > cash Flow > cash From Operations
-3034118
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
2644912
Annuals > 0 > cash Flow > net Change In Cash
-331303
Annuals > 0 > cash Flow > currency_symbol
CAD
Annuals > 0 > ratios > PE
-0.04683779899852829
Annuals > 0 > ratios > PB
-5.2536102251999
Annuals > 0 > ratios > ROE
67.56384946307683
Annuals > 0 > ratios > ROA
-932.8986309069033
Annuals > 0 > ratios > FCF
-3034118
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-112.4372058551047
Annuals > 0 > health Score
30
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
372247
Annuals > 1 > income Statement > cost Of Revenue
0
Annuals > 1 > income Statement > gross Profit
372247
Annuals > 1 > income Statement > operating Expenses
6759484
Annuals > 1 > income Statement > operating Income
-6387237
Annuals > 1 > income Statement > interest Expense
1042546
Annuals > 1 > income Statement > pretax Income
-7722927
Annuals > 1 > income Statement > net Income
-7722927
Annuals > 1 > income Statement > eps
-0.07194219157847347
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
107349065
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-1715.8598994753484
Annuals > 1 > income Statement > total Other Income Expense Net
-293144
Annuals > 1 > income Statement > currency_symbol
CAD
Annuals > 1 > balance Sheet > cash
363655
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
282563
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
719027
Annuals > 1 > balance Sheet > property Plant Equipment
548528
Annuals > 1 > balance Sheet > total Assets
1267557
Annuals > 1 > balance Sheet > payables
598499
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
6550219
Annuals > 1 > balance Sheet > equity
-5282662
Annuals > 1 > balance Sheet > currency_symbol
CAD
Annuals > 1 > cash Flow > net Income
-7722927
Annuals > 1 > cash Flow > depreciation
195763
Annuals > 1 > cash Flow > change In Working Capital
481204
Annuals > 1 > cash Flow > cash From Operations
-5167565
Annuals > 1 > cash Flow > capital Expenditures
201421
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
5293416
Annuals > 1 > cash Flow > net Change In Cash
227459
Annuals > 1 > cash Flow > currency_symbol
CAD
Annuals > 1 > ratios > PE
-0.07194219157847347
Annuals > 1 > ratios > PB
-7.400914439159651
Annuals > 1 > ratios > ROE
146.19385075176115
Annuals > 1 > ratios > ROA
-609.27650590861
Annuals > 1 > ratios > FCF
-5368986
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-14.423181382254256
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
297442
Annuals > 2 > income Statement > cost Of Revenue
101827
Annuals > 2 > income Statement > gross Profit
195615
Annuals > 2 > income Statement > operating Expenses
6342370
Annuals > 2 > income Statement > operating Income
-6044928
Annuals > 2 > income Statement > interest Expense
1142562
Annuals > 2 > income Statement > pretax Income
-12869985
Annuals > 2 > income Statement > net Income
-12376071
Annuals > 2 > income Statement > eps
-0.13568784379296306
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
91209873
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-11511821
Annuals > 2 > income Statement > operating Margin
-2032.3047854707809
Annuals > 2 > income Statement > total Other Income Expense Net
-5682495
Annuals > 2 > income Statement > currency_symbol
CAD
Annuals > 2 > balance Sheet > cash
136196
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
458717
Annuals > 2 > balance Sheet > inventories
0
Annuals > 2 > balance Sheet > total Current Assets
691106
Annuals > 2 > balance Sheet > property Plant Equipment
921472
Annuals > 2 > balance Sheet > total Assets
1612590
Annuals > 2 > balance Sheet > payables
461040
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
3723644
Annuals > 2 > balance Sheet > total Liabilities
5740985
Annuals > 2 > balance Sheet > equity
-4128395
Annuals > 2 > balance Sheet > currency_symbol
CAD
Annuals > 2 > cash Flow > net Income
-12376071
Annuals > 2 > cash Flow > depreciation
208966
Annuals > 2 > cash Flow > change In Working Capital
-559548
Annuals > 2 > cash Flow > cash From Operations
-6229715
Annuals > 2 > cash Flow > capital Expenditures
3858
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
5022764
Annuals > 2 > cash Flow > net Change In Cash
-1215785
Annuals > 2 > cash Flow > currency_symbol
CAD
Annuals > 2 > ratios > PE
-0.13568784379296306
Annuals > 2 > ratios > PB
-8.046380190509872
Annuals > 2 > ratios > ROE
299.77923624071826
Annuals > 2 > ratios > ROA
-767.4654437891838
Annuals > 2 > ratios > FCF
-6233573
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-20.95727234217091
Annuals > 2 > health Score
31
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
286498
Annuals > 3 > income Statement > cost Of Revenue
87020
Annuals > 3 > income Statement > gross Profit
199478
Annuals > 3 > income Statement > operating Expenses
16596548
Annuals > 3 > income Statement > operating Income
-16310050
Annuals > 3 > income Statement > interest Expense
731865
Annuals > 3 > income Statement > pretax Income
-20747843
Annuals > 3 > income Statement > net Income
-20637104
Annuals > 3 > income Statement > eps
-0.2595306057315971
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
79517034
Annuals > 3 > income Statement > income Tax Expense
-110739
Annuals > 3 > income Statement > EBITDA
-19192763
Annuals > 3 > income Statement > operating Margin
-5692.901870170123
Annuals > 3 > income Statement > total Other Income Expense Net
-3705928
Annuals > 3 > income Statement > currency_symbol
CAD
Annuals > 3 > balance Sheet > cash
1351981
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
546322
Annuals > 3 > balance Sheet > inventories
736164
Annuals > 3 > balance Sheet > total Current Assets
2703860
Annuals > 3 > balance Sheet > property Plant Equipment
1129186
Annuals > 3 > balance Sheet > total Assets
9726618
Annuals > 3 > balance Sheet > payables
2320225
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
1661279
Annuals > 3 > balance Sheet > total Liabilities
8057974
Annuals > 3 > balance Sheet > equity
1668644
Annuals > 3 > balance Sheet > currency_symbol
CAD
Annuals > 3 > cash Flow > net Income
-20637104
Annuals > 3 > cash Flow > depreciation
823215
Annuals > 3 > cash Flow > change In Working Capital
-418730
Annuals > 3 > cash Flow > cash From Operations
-12155051
Annuals > 3 > cash Flow > capital Expenditures
452347
Annuals > 3 > cash Flow > cash From Investing
-5307959
Annuals > 3 > cash Flow > cash From Financing
16230472
Annuals > 3 > cash Flow > net Change In Cash
-1232962
Annuals > 3 > cash Flow > currency_symbol
CAD
Annuals > 3 > ratios > PE
-0.2595306057315971
Annuals > 3 > ratios > PB
17.355471738010024
Annuals > 3 > ratios > ROE
-1236.7589491826895
Annuals > 3 > ratios > ROA
-212.17142484674528
Annuals > 3 > ratios > FCF
-12607398
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-44.005186772682535
Annuals > 3 > health Score
8
Valuation > metrics > PE
-0.013235028447515016
Valuation > metrics > PB
-5.310429144022974
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
19.29810016190469
Profitability > metrics > ROA
-182.71030805687204
Profitability > metrics > Net Margin
-142.48027718550105
Profitability > final Score
39
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-3.4002600882723835
Risk > final Score
16
Risk > verdict
High
Liquidity > metrics > Current Ratio
1.8292383036365532
Liquidity > metrics > Quick Ratio
1.8292383036365532
Liquidity > final Score
96
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
46
Prev Profitabilities > 1
55
Prev Profitabilities > 2
33
Prev Risks > 0
18
Prev Risks > 1
1
Prev Risks > 2
14
Prev Liquidities > 0
24
Prev Liquidities > 1
49
Prev Liquidities > 2
17
Updated At
2026-01-20T21:30:51.128Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-28
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.0099
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-09-01
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.0081
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-06-27
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.0119
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-09-30
Earnings History > 3 > report Date
2024-11-29
Earnings History > 3 > date
2024-09-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
CAD
Earnings History > 3 > eps Actual
-0.0095
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-06-30
Earnings History > 4 > report Date
2024-08-26
Earnings History > 4 > date
2024-06-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
CAD
Earnings History > 4 > eps Actual
-0.0065
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-03-31
Earnings History > 5 > report Date
2024-05-29
Earnings History > 5 > date
2024-03-31
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
CAD
Earnings History > 5 > eps Actual
-0.0107
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2023-09-30
Earnings History > 6 > report Date
2023-12-05
Earnings History > 6 > date
2023-09-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
CAD
Earnings History > 6 > eps Actual
-0.0106
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2023-06-30
Earnings History > 7 > report Date
2023-08-30
Earnings History > 7 > date
2023-06-30
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
CAD
Earnings History > 7 > eps Actual
-0.0178
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2023-03-31
Earnings History > 8 > report Date
2023-05-26
Earnings History > 8 > date
2023-03-31
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
CAD
Earnings History > 8 > eps Actual
-0.0118
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2022-09-30
Earnings History > 9 > report Date
2022-11-28
Earnings History > 9 > date
2022-09-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
CAD
Earnings History > 9 > eps Actual
-0.0177
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2022-06-30
Earnings History > 10 > report Date
2022-08-29
Earnings History > 10 > date
2022-06-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
CAD
Earnings History > 10 > eps Actual
-0.0132
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2022-03-31
Earnings History > 11 > report Date
2022-04-28
Earnings History > 11 > date
2022-03-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
CAD
Earnings History > 11 > eps Actual
-0.11
Earnings History > 11 > eps Estimate
-0.03
Earnings History > 11 > eps Difference
-0.08
Earnings History > 11 > surprise Percent
-266.6667
Earnings History > 12 > period
2021-12-31
Earnings History > 12 > report Date
2021-12-31
Earnings History > 12 > date
2021-12-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
CAD
Earnings History > 12 > eps Actual
-0.11
Earnings History > 12 > eps Estimate
-0.03
Earnings History > 12 > eps Difference
-0.08
Earnings History > 12 > surprise Percent
-266.6667
Earnings History > 13 > period
2021-09-30
Earnings History > 13 > report Date
2021-11-26
Earnings History > 13 > date
2021-09-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
CAD
Earnings History > 13 > eps Actual
-0.04
Earnings History > 13 > eps Estimate
-0.06
Earnings History > 13 > eps Difference
0.02
Earnings History > 13 > surprise Percent
33.3333
Earnings History > 14 > period
2021-06-30
Earnings History > 14 > report Date
2021-08-27
Earnings History > 14 > date
2021-06-30
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
CAD
Earnings History > 14 > eps Actual
-0.0501
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2021-03-31
Earnings History > 15 > report Date
2021-05-05
Earnings History > 15 > date
2021-03-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
CAD
Earnings History > 15 > eps Actual
-0.065
Earnings History > 15 > eps Estimate
-
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2020-12-31
Earnings History > 16 > report Date
2020-12-31
Earnings History > 16 > date
2020-12-31
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
CAD
Earnings History > 16 > eps Actual
-0.0346
Earnings History > 16 > eps Estimate
-
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2020-09-30
Earnings History > 17 > report Date
2020-09-30
Earnings History > 17 > date
2020-09-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
CAD
Earnings History > 17 > eps Actual
-0.0858
Earnings History > 17 > eps Estimate
-
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2020-06-30
Earnings History > 18 > report Date
2020-06-30
Earnings History > 18 > date
2020-06-30
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
CAD
Earnings History > 18 > eps Actual
-0.0463
Earnings History > 18 > eps Estimate
-
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2020-03-31
Earnings History > 19 > report Date
2020-03-31
Earnings History > 19 > date
2020-03-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
CAD
Earnings History > 19 > eps Actual
-0.0529
Earnings History > 19 > eps Estimate
-
Earnings History > 19 > eps Difference
0
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2019-12-31
Earnings History > 20 > report Date
2019-12-31
Earnings History > 20 > date
2019-12-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
CAD
Earnings History > 20 > eps Actual
-0.0331
Earnings History > 20 > eps Estimate
-
Earnings History > 20 > eps Difference
0
Earnings History > 20 > surprise Percent
-
BioNxt Solutions Inc. engages in research, development, manufacture, and sale of next generation drug formulations and delivery systems in Austria, Germany, and Switzerland. The company provides BNT23001for the treatment of multiple sclerosis; BNT23002 for the treatment of myasthenia gravis; BNT24002, a sublingual thin film for the treatment of lupus nephritis; BNT24003 for the treatment of rheumatoid arthritis; BNT24004 for longevity and anti-aging; and BNT24004 for the treatment of semaglutide. It also offers diagnostic screening tests; new active pharmaceutical production and evaluation, including precision transdermal and oral dissolvable drug formulations; infectious disease and oral health screening tests; and standardization and clinical evaluation of emerging active pharmaceutical ingredients for neurological applications. The company was formerly known as XPhyto Therapeutics Corp. and changed its name to BioNxt Solutions Inc. in November 2022. BioNxt Solutions Inc. was incorporated in 2017 and is headquartered in Vancouver, Canada.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ASublingual MS film boosts cladribine exposure in pigs by ~40% Stock Titan
Read more →Pig study backs easier-to-take MS cladribine film with higher absorption Stock Titan
Read more →Showing 2 of 8
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 0.00% of the total shares of BioNxt Solutions Inc.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.0099
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.